Jefferies initiated Helus Pharma stock with a Buy rating on future catalysts




Jefferies initiated Helus Pharma stock with a Buy rating on future catalysts



Source link

  • Related Posts

    Chevron Q4 2025 Net Income Falls 12.5% ​​to $2.84 Billion

    Chevron reported net income of $2.84 billion in the fourth quarter of 2025 (4Q 2025), which ended on December 31, 2025, a decrease of approximately 12.5% ​​compared to $3.25 billion…

    TDK Q3 FY2026 slides: Record sales 26.5% revenue rise, raises guidance

    TDK Q3 FY2026 slides: Record sales 26.5% revenue rise, raises guidance Source link

    Leave a Reply

    Your email address will not be published. Required fields are marked *